Cargando…
Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445523/ https://www.ncbi.nlm.nih.gov/pubmed/34729146 http://dx.doi.org/10.1177/20406223211046076 |
| _version_ | 1784568676046864384 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8445523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84455232021-11-01 Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” Ther Adv Chronic Dis Corrigendum SAGE Publications 2021-09-14 /pmc/articles/PMC8445523/ /pubmed/34729146 http://dx.doi.org/10.1177/20406223211046076 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Corrigendum Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| title | Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| title_full | Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| title_fullStr | Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| title_full_unstemmed | Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| title_short | Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| title_sort | corrigendum to “rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis” |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445523/ https://www.ncbi.nlm.nih.gov/pubmed/34729146 http://dx.doi.org/10.1177/20406223211046076 |